Rakovina Therapeutics receives government grant to accelerate novel cancer therapy program

--News Direct--

Rakovina Therapeutics chief scientific officer Mads Daugaard joined Proactive's Steve Darling to share news the company is receiving research and development funding from the National Research Council of Canada Industrial Research Assistance Program.

Daugaard tells Proactive the non-dilutive financing will provide its scientists in the development of DNA-damage response inhibitors with the goal of selecting one or more lead compounds for advancement to either toxicology and/or investigational new drug studies.

Contact Details

Proactive Investors

+1 604-688-8158


View source version on newsdirect.com: https://newsdirect.com/news/rakovina-therapeutics-receives-government-grant-to-accelerate-novel-cancer-therapy-program-514861447

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.